Drug-resistant juvenile myoclonic epilepsy: A literature review
A Nica - Revue Neurologique, 2024 - Elsevier
Abstract The ILAE's Task Force on Nosology and Definitions revised in 2022 its definition of
juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy …
juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy …
[HTML][HTML] A systematic review and meta-analysis of factors related to first line drugs refractoriness in patients with juvenile myoclonic epilepsy (JME)
Introduction Juvenile Myoclonic Epilepsy (JME) is a prevalent form of epileptic disorder,
specifically categorized within the realm of Genetic Generalized Epilepsy (GGE). Its hallmark …
specifically categorized within the realm of Genetic Generalized Epilepsy (GGE). Its hallmark …
Concepts and controversies of juvenile myoclonic epilepsy: still an enigmatic epilepsy
Juvenile myoclonic epilepsy (JME) is a clinically and genetically heterogenous, generalized
epilepsy syndrome usually starting in adolescence. An age-related, predominantly …
epilepsy syndrome usually starting in adolescence. An age-related, predominantly …
[HTML][HTML] Drug-resistant juvenile myoclonic epilepsy: misdiagnosis of progressive myoclonus epilepsy
S Martin, A Strzelczyk, S Lindlar, K Krause… - Frontiers in …, 2019 - frontiersin.org
Juvenile myoclonic epilepsy (JME) is a common epilepsy syndrome characterized by
bilateral myoclonic and tonic-clonic seizures typically starting in adolescence and …
bilateral myoclonic and tonic-clonic seizures typically starting in adolescence and …
Modern management of juvenile myoclonic epilepsy
MJ Brodie - Expert review of neurotherapeutics, 2016 - Taylor & Francis
Juvenile myoclonic epilepsy (JME) is a common genetic epilepsy syndrome usually
presenting in adolescence and characterized by myoclonic jerks, predominately in the arms …
presenting in adolescence and characterized by myoclonic jerks, predominately in the arms …
[HTML][HTML] Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road
N Baheti, C Rathore, AR Bansal, S Shah, HK Veedu… - Seizure, 2021 - Elsevier
Objective To determine treatment responses to various antiseizure medicines (ASMs) in
patients with drug resistant juvenile myoclonic epilepsy (DRJME) Methods We reviewed …
patients with drug resistant juvenile myoclonic epilepsy (DRJME) Methods We reviewed …
Variation in prognosis and treatment outcome in juvenile myoclonic epilepsy: a Biology of Juvenile Myoclonic Epilepsy Consortium proposal for a practical definition …
Reliable definitions, classifications and prognostic models are the cornerstones of stratified
medicine, but none of the current classifications systems in epilepsy address prognostic or …
medicine, but none of the current classifications systems in epilepsy address prognostic or …
Refractory juvenile myoclonic epilepsy: a meta‐analysis of prevalence and risk factors
Background and purpose Juvenile myoclonic epilepsy (JME) is a common epilepsy
syndrome for which treatment response is generally assumed to be good. We aimed to …
syndrome for which treatment response is generally assumed to be good. We aimed to …
Lifetime prognosis of juvenile myoclonic epilepsy
B Baykan, IE Martínez-Juárez, EA Altindag… - Epilepsy & behavior, 2013 - Elsevier
Juvenile myoclonic epilepsy (JME) is among the most common types of genetic epilepsies,
displaying a good prognosis when treated with appropriate drugs, but with a well-known …
displaying a good prognosis when treated with appropriate drugs, but with a well-known …
[HTML][HTML] Juvenile myoclonic epilepsy: Challenges on its 60th anniversary
EM Yacubian - Seizure, 2017 - Elsevier
Purpose Since its initial 1957 description, juvenile myoclonic epilepsy (JME) has been
recognized as a common epileptic syndrome worldwide. Methods We reviewed a series of …
recognized as a common epileptic syndrome worldwide. Methods We reviewed a series of …